AstraZeneca PLC (AZN)

11,200.0
-60.0(-0.53%)
  • Volume:
    33,788
  • Bid/Ask:
    11,146.0/11,258.0
  • Day's Range:
    11,170.0 - 11,268.0

AZN Overview

Prev. Close
11,260
Day's Range
11,170-11,268
Revenue
32.47B
Open
11,234.4
52 wk Range
8,090.3-11,540
EPS
1.32
Volume
33,788
Market Cap
173.81B
Dividend (Yield)
221.70
(1.97%)
Average Volume (3m)
1,737,658
P/E Ratio
99.63
Beta
0.168
1-Year Change
37.47%
Shares Outstanding
1,549,528,211
Next Earnings Date
02 Feb 2023
What is your sentiment on AstraZeneca?
or
Vote to see community's results!

AstraZeneca PLC News

AstraZeneca PLC Analysis

AstraZeneca PLC Company Profile

AstraZeneca PLC Company Profile

Employees
83100

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company’s marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyNeutralBuyStrong Buy
Technical IndicatorsSellNeutralSellStrong BuyStrong Buy
SummaryNeutralNeutralNeutralStrong BuyStrong Buy
  • Rizwan baig
    0
    • don't shorts from technical analysis informa will move from 11,158 to 11345.4 today target 🎯so buy quickly. don't short. if downtrend going then strongly buy.
      2
      • don't shorts from analysis AZN will move from now 11,158 today target 11345.78 easily movement🎯so buy quickly.
        1
        • iam new don't know anything doesnt even have a bank account can someone help?
          0
          • hi I'm new here please help
            0
            • I'm happy to trade with you
              1
              • good.., are you free 🙂
                2
                • yeh I am..
                  0
              • Just buy and hold it as long as u can
                1
                • hi
                  0
                  • am new here
                    0